Avid Bioservices Inc (CDMO)

[itsabouttime]

Hutschi- we now can say...

The MOA of Bavi with its efficacy should not only increase eligibility of patients for treatment but improve quality,lower side effects,help elicit a curative regimen combined with
Yervoy an anti-CTLA-4 antibody.





Important Safety Information for OPDIVO (nivolumab)and the OPDIVO+YERVOY Regimen

YERVOY® (ipilimumab) can cause serious side effects in many parts of your body which can lead to death. These serious side effects may include: intestinal problems (colitis) that can cause tears or holes (perforation) in the intestines; liver problems (hepatitis) that can lead to liver failure; skin problems that can lead to severe skin reaction; nerve problems that can lead to paralysis; hormone gland problems (especially the pituitary, adrenal, and thyroid glands); and eye problems.

These problems may happen anytime during treatment with YERVOY or after you have completed treatment. Your healthcare provider will check you for these problems during treatment with YERVOY. Your healthcare provider may treat you with corticosteroid medicines. Your healthcare provider should perform blood tests, such as liver, hormone, and thyroid function tests, before starting and during treatment with YERVOY. Your healthcare provider may need to delay or completely stop treatment with YERVOY if you have severe side effects.